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The Brucella BvrRBvrS two-component regulatory system is ho-
mologous to the ChvIChvG systems of Sinorhizobium meliloti and
Agrobacterium tumefaciens necessary for endosymbiosis and
pathogenicity in plants. BvrRBvrS controls cell invasion and in-
tracellular survival. Probing the surface of bvrR and bvrS transpo-
son mutants with monoclonal antibodies showed all described
major outer membrane proteins (Omps) but Omp25, a protein
known to be involved in Brucella virulence. Absence of Omp25
expression was confirmed by two-dimensional electrophoresis of
envelope fractions and by gene reporter studies. The electro-
phoretic analysis also revealed reduction or absence in the mutants
of a second set of protein spots that by matrix-assisted laser
desorption ionization MS and peptide mass mapping were iden-
tified as a non-previously described Omp (Omp3b). Because bvrR
and bvrS mutants are also altered in cell-surface hydrophobicity,
permeability, and sensitivity to surface-targeted bactericidal pep-
tides, it is proposed that BvrRBvrS controls cell envelope changes
necessary to transit between extracellular and intracellular envi-
ronments. A genomic search revealed that Omp25 (Omp3a) and
Omp3b belong to a family of Omps of plant and animal cell-
associated -Proteobacteria, which includes Rhizobium legumino-
sarum RopB and A. tumefaciens AopB. Previous work has shown
that RopB is not expressed in bacteroids, that AopB is involved in
tumorigenesis, and that dysfunction of A. tumefaciens ChvIChvG
alters surface properties. It is thus proposed that the BvrRBvrS and
Omp3 homologues of the cell-associated -Proteobacteria play a
role in bacterial surface control and host cell interactions.
The brucellae are facultative intracellular parasites of animalsand humans causing a disease of worldwide importance.
These bacteria are phylogenetically entwined with animal and
plant cell-associated Proteobacteria of the  subclass, such as
Rhizobium, Sinorhizobium, Mesorhizobium, Agrobacterium, Bar-
tonella, and Rickettsia species. Similar to other facultative intra-
cellular parasites, Brucella organisms survive outside cells, but
they must infect and replicate intracellularly in animals to
perpetuate. The brucellae are extremely well adapted to the
intracellular niche and, accordingly, they should be described as
facultatively extracellular intracellular parasites (1).
Brucella organisms have to deal with two very different
environments during their life cycle. On one hand, the extracel-
lular milieu confronts the bacteria with bactericidal substances
such as antibodies, antibiotics, complement, and leukocyte dis-
charges. On the other, the bacteria must invade cells and resist
the various cellular strategies aimed to eliminate parasites. It is
thus predicted that some genetic systems are turned on and off
to achieve the adjustments in metabolism and structure neces-
sary for a successful extracellularintracellular life transition. So
far, only one such system, the two-component regulatory system
BvrRBvrS, has been conclusively implicated in Brucella viru-
lence (2). BvrRBvrS mutants are avirulent in mice, show
reduced invasiveness in cells, and are unable to inhibit lysosome
fusion and to replicate intracellularly (2). Dysfunction of bvrR
bvrS diminishes the characteristic resistance of Brucella to
bactericidal polycations and increases its permeability to surfac-
tants. Because these properties relate to the structure of the
Brucella outer membrane (3–5), we reasoned that some of its
molecular features should be under the control of BvrRBvrS.
This membrane has overall properties that depart from those of
many Gram-negative bacteria, including a complex outer mem-
brane protein (Omp) profile (reviewed in ref. 5). Brucella Omps
were originally grouped by their mobility in SDSPAGE as
group 1 (94 or 89 kDa), group 2 (38–36 kDa), and group 3 (31–25
kDa). Group 2 Omps are porins, and Omp25, of group 3, has
been recently shown to be involved in virulence (6, 7). In
addition, three lipoproteins (10–19 kDa) and a peptidoglycan
bound lipoprotein have been identified (5).
The BvrRBvrS system is highly homologous to some two-
component systems of cell associated -2 Proteobacteria (2):
BvrR has 86–76% similarity to Mesorhizobium loti ChvI, Bar-
tonella bacilliformis BatR, Sinorhizobium meliloti ChvI, and
Agrobacterium tumefaciens ChvI, and BvrS has 68–59% similar-
ity to M. loti ExoS, S. meliloti ExoS, B. bacilliformis BatS, and A.
tumefaciens ChvG. It has been demonstrated that the ChvIExoS
system of S. meliloti controls the succinoglycan production
necessary for endosymbiosis (8). Also, A. tumefaciens ChvI
ChvG mutants are not tumorigenic in plants, are comparatively
sensitive to detergents, antibiotics, and acid pH, and have altered
cell envelope permeability (9, 10). However, little is known on
the molecular determinants controlled by these regulatory sys-
tems. In the present study, we analyzed the expression of Omps
in wild type and bvrR and bvrS mutants. We report that
BvrRBvrS regulates the expression of at least two Omps, one
not described previously and the other known to be involved in
Brucella virulence. Genomic comparisons showed that homol-
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ogous proteins are present in animal and plant cell associated
-Proteobacteria, and perusal of the literature suggests that at least
some of them play a critical role in bacterial–host cell interactions.
Experimental Procedures
Bacterial Strains, Plasmids, and Growth Conditions. The strains and
plasmids used are described in Table 1. E. coli was grown in LB
and Brucella in tryptic soy medium. For isolation of bacterial
fractions, cells were propagated as described (11). When needed,
nalidixic acid at 25 gml, ampicillin at 100 gml, kanamycin
at 50 gml, or gentamicin at 20 gml was added to the
medium.
Bacterial Fractionation. Cell envelopes and cytosolic fractions
were obtained and characterized as described (12). The outer
membrane fragments released by exponentially growing brucel-
lae were obtained by ultracentrifugation of spent broth. This
fraction is devoid of cytoplasmic or inner membrane markers
and is enriched in Brucella group 3 Omps (13). LPS extracts rich
in tightly bound, protease-resistant group 3 Omps were obtained
from live bacteria with SDS and proteinase K as described (14).
Analysis of Omps by PAGE. Standard SDSPAGE was performed
according to Laemmli (15). Proteins were detected by the
Coomassie G or silver staining methods (16). Total cell lysates
for two-dimensional gel electrophoresis (2DGE) were obtained
from overnight cultures. Bacteria were collected by centrifuga-
tion, washed twice with PBS, resuspended in sample buffer
without SDS or -mercaptoethanol (15), and boiled for 10 min.
To analyze cell envelopes or outer membrane fragments by
2DGE, 300 g of these materials were precipitated with 80%
acetone, and aliquots were first run by SDSPAGE to normalize
total protein content. First dimensions were performed on
Immobiline DryStrip gels (Pharmacia Biotech) according to the
manufacturer’s instructions. After second-dimension separation
by SDSPAGE and silver staining (16), gels were dried, scanned,
and compared using Z3 software (Compugen, Jamesburg, NJ).
For comparative purposes, at least five independent 2DGE
analyses were performed with each material.
Matrix-Assisted Laser Desorption Ionization (MALDI)-MS and Peptide
Mass Mapping. One milligram of outer membrane fragments from
the different strains was precipitated with acetone for 20 min and
resuspended in 60 l of isoelectrofocusing lysis buffer, and
2DGE was performed as described above. After Coomassie
staining, the proteins were localized by using reference spots
from the same gel, from silver stained gels, and from Western
blots run in parallel by using the same sample. Protein spots cut
out from the gels were analyzed by tandem MS and MALDI-MS
followed by peptide mass mapping at the Laboratoire de Chimie
des Proteines (CEA, Grenoble, France) or at Bruker Daltonik
(Bremen, Germany).
Immunochemical Methods. For dot-blot analysis, 5 l of cell
envelope suspensions (5 mg proteinml in water) was dispensed
onto poly(vinylidene dif luoride) membranes (Schleicher &
Schuell), which were then incubated overnight in a humid
atmosphere, washed with 0.1% Tween 20 in PBS, and blocked
overnight with 3% skim milk in the same solution. Amido black
staining before blotting showed no quantitative differences in
adsorption of proteins obtained from mutants or wild-type
bacteria. Membranes were incubated with monoclonal antibod-
ies (mAbs), washed (see above), and revealed with peroxidase-
conjugated goat anti-mouse antibodies (Nordic, Tilburg, The
Netherlands) and 4-chloro-1-naphthol (Merck). For Western
blot, the same mAbs were used and revealed either with perox-
idase-conjugated protein G and 4-chloro-1-naphthol or with a
peroxidase-labeled secondary antibody and a chemilumines-
cence kit (Roche). mAbs to the following Omps were used
(17–19): Omp10 (A6807G11C10), Omp16 (A6808C03
G03), Omp19 (A7605C10A08, A7618B02D06), Omp25
(A1813D02F05, A1912B10F04, A5905F01C09, A70
06B05A07, A7602C12C11, A6804B10F05, A6807D11
B03, A6828G06C07), Omp2b (Omp36) (A6308D08C07,
A6305A07A08, A6303H02B01, A6311E05D11, A63
13G02C04, A6304D11G01, A6825G05A05), and Omp1
(Omp89) (A5310B02A01). Anti-Omp25 mAbs A1813D02
F05, A1912B10F04, and A5905F01C09 recognize a linear
epitope close to the amino-terminal section (amino acids 21–40).
A mAb against the CY epitope was conjugated with peroxidase
(20), and was used for LPS detection.
Chromosomal omp3a::lacZ and omp3b::lacZ Transcriptional Fusions
and -Galactosidase Assays. To construct a lacZ under the tran-
scriptional control of the omp3a promoter, a promoterless
omp3a 550-bp DNA fragment was synthesized by PCR using
oligonucleotides annealing at positions 255 (5-TGCGCTGCT-
GCCGTTCTCTG-3) and 776 (5-GGATCCGGCCAGAT-
CATAGTTCTTGT-3; where the italics mark the terminal
extension containing a BamHI restriction site) of Brucella abor-
tus 544 omp3a (omp25) sequence (GenBank accession no.
X79284). The PCR product was cloned into vector pCR2.1
(Invitrogen), and then subcloned into the promoter probe vector
pEGZ (Table 1; ref. 21). The suicide plasmid generated, pEGZ-
omp3a, encoding an omp3a::lacZ fusion, was delivered into the
appropriate B. abortus strain by mating with E. coli SM10 -pir,
resulting in the construction of 2308::pEGZ-omp3a,
2.13::pEGZ-omp3a, 65.21::pEGZ-omp3a, and 65.21p::pEGZ-
omp3a. Correct integration of pEGZ-omp3a was confirmed
by Southern blot and PCR. Construction of strains
Table 1. Bacterial strains and plasmids
Strain or plasmid Relevant characteristics Source
B. abortus
2308 Nalr Wild type, virulent, smooth-LPS, Nalr spontaneous mutant of strain 2308 Ref. 40
2.13 2308 Nalr, bvrSTn5, Kanr, avirulent, smooth LPS Ref. 2
65.21 2308 Nalr, bvrRTn5, Kanr, avirulent, smooth LPS Ref. 2
65.21p Reconstituted bvrR strain, 65.21 carrying plasmid pBBR1MCS-4 with a 6.0-kb fragment encoding bvrR Ref. 2
E. coli
SM10 ( pir) recARP4-2-TetMu, Kmr, thi leu thr supE  pir Ref. 41
Plasmids
pCR2.1 Cloning vector, pUC ori, Ampr, Kmr Invitrogen
pEGZ Suicide plasmid used to generate chromosomal lacZ fusions, Ampr, Gmr Ref. 42
pEGZ-omp3a Promoterless omp3a 550 bp fragment cloned upstream the promoterless lacZ into vector pEGZ This study
pEGZ-omp3b Promoterless omp3b 473 bp fragment cloned upstream the promoterless lacZ into vector pEGZ This study
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2308::pEGZ-omp3b, 2.13::pEGZ-omp3b, 65.21::pEGZ-omp3b,
and 65.21p::pEGZ-omp3b was performed likewise, but using a
promoterless omp3b 473-bp DNA fragment synthesized by PCR
using oligonucleotides annealing at positions 379 (5-
GCGCGCAGGTTGGTGGTT-3) and 827 (5-GGATCCGC-
CGGCCTTGATCGAATG-3) of the omp3b sequence. The
-galactosidase activity was assessed as described (22), and
specific activity was expressed as nmol of o-nitrophenol pro-
ducedmin  mg protein.
Cloning and Nucleotide Sequencing of B. abortus 2308 omp3b. Partial
amino acid sequences obtained by MALDI-MS and peptide
mass mapping from the Omp3b spots resolved by 2DGE were
compared against preliminary B. suis complete genome se-
quence data (see below). Based on this, the following oligonu-
cleotides were designed: (5-CCCGGCTGTTACATATGCTG-
3) and (5-CGCGCTGATATCGACATGAC-3). A PCR was
performed using Pfu DNA polymerase (Stratagene) and the
1.1-kbp product was subsequently cloned into pCR2.1 (Invitro-
gen). Sequencing was performed with universal M13 primers by
Sistemas Geno´micos (Valencia, Spain). DNA sequences were
assembled and analyzed using the GENEWORK V.2.45N (Intelli-
Genetics) program.
Nucleotide and Protein Sequence Analyses. Comparison of se-
quences, search for homologies, and analyses of protein char-
acteristics (hydrophobicity profiles, localization site and signal
sequence, and secondary and tertiary structure) were obtained
using standard software (www.tigr.org; www.expasy.org; http:
psort.nibb.ac.jpform.html; www.bmm.icnet.uk3dpssm;
http:bibiserv.techfak.uni-bielefeld.dedialign). For the con-
struction of the neighbor-joining tree, protein sequences were
aligned using the CLUSTAL W program and a matrix of Dayhoff
was generated (www.infobiogen.frservicesmenuserv.html).
Results
Dysfunction of bvrR and bvrS Alters the Profile of B. abortus Group 3
Omps. As pointed out in the Introduction, indirect evidence
suggests that transposon mutants in either bvrR or bvrS have an
altered cell envelope. Thus, as a first approach to identify
changes in outer membrane components, we probed the cell
surface of the wild-type (parental) and mutant strains by dot blot
with a collection of mAbs recognizing all hitherto described B.
abortus Omps. In contrast to the wild-type and bvrR reconsti-
tuted 65.21p strain, Omp25 was not or barely detected on the
BvrRBvrS mutants despite the several epitope specificities of
the anti-Omp25 mAbs used (data not shown). All other Omps
described so far in B. abortus (Omp10, Omp16, Omp19, Omp2b,
and Omp1) were similarly immunodetected on both mutants, the
wild-type and the reconstituted bvrR strain (data not shown). It
is distinctive of Brucella group 3 Omps (to which Omp25
belongs) to be tightly bound to LPS in the outer membrane in a
form partially resistant to protease digestion, and to coextract
with this molecule (13, 23). Thus, SDS-proteinase K extracts and
outer membrane fragments were examined by SDSPAGE, and
these analyses showed that the intensity of the band correspond-
ing to group 3 proteins was weaker in the bvrR and bvrS mutants
than in the wild type (Fig. 1). Consistent with the dot-blot results,
Omp25 was not detected by Western blotting in SDS-proteinase
K extracts of the mutants, but traces of this protein were detected
in the outer membrane fragments of the bvrS mutant (Fig. 1).
To clarify the small discrepancies observed in the above-
described analyses, and also to explore other possible differences
in Omp profiles, the outer membrane fractions were examined
by 2DGE. This method confirmed and extended the previous
findings because it revealed that two sets of proteins were either
considerably reduced or beyond detection in the mutants. The
first set consisted of three protein spots [all marked similarly as
Omp3a (see below) in Fig. 2A] of about 25 kDa, with an
intermediate isoelectric point of 5.4, and the second set consisted
of five protein spots [all marked similarly as Omp3b (see below)
in Fig. 2 A] of about 27 kDa, with an intermediate isoelectric
point of 8.2. As compared with the wild type (Fig. 2 A), spots
marked as Omp3b were considerably diminished in the bvrR
mutant (not shown) and beyond detection in the bvrS mutant
(Fig. 2B). These differences were observed consistently in all
preparations, and were further confirmed by 2DGE analysis of
the whole cell envelope fraction (not shown). Comparative lack,
reduction, or presence of other spots was also evident in outer
membrane fragments of the mutants. One spot, marked as ‘‘a’’
(Fig. 2 A and B) was considerably reduced in the bvrS mutant and
not detected in the bvrR mutant (not shown). On the other hand,
spots marked as , , and  were detected in outer membrane
fragments of the bvrS mutant but not in the wild-type or the bvrR
mutant (Fig. 2 A and B and data not shown).
To establish the correspondence between the dot-blot, SDS
PAGE, and 2DGE results, an anti-Omp25 mAb reacting against
a linear epitope was used in Western blots of two-dimensional
gels. At least nine major spots (including the three Omp3a spots)
in the wild type and one discrete spot in the bvrS mutant were
detected (Fig. 2 C and D). Therefore, the Omp3a spots (Fig. 2 A)
corresponded to Omp25. The resolution of Omp3a into several
spots by 2DGE could result from several phenomena. Proteo-
lytic degradation could account for large differences (for exam-
ple, spots 4, 5, and 6 in Fig. 2C), secondary modifications for
small differences in molecular weight (for example, between
spots 2 and 3 in Fig. 2C), and interactions with charged molecules
could generate shifts in isoelectric points without large changes
in molecular weight (for example, spots 7–9 in Fig. 2C). In this
regard, strong interactions between group 3 Omps and LPS have
been shown (refs. 23 and 24; see also below). Because Brucella
Omps clustering around 25 kDa were adequately designated as
group 3 Omps in early studies (25), the name Omp3a should
be preferred over Omp25. This is consistent with the accepted
use of the names Omp2a and Omp2b (26) for the two porin
proteins of Brucella, which were assigned to group 2 in the
same studies (25).
Of the additional spots recognized by the same anti-Omp25
(Omp3a) mAb, two major ones (spots 7 and 8 in Fig. 2C) were
resistant to proteolytic digestion and, therefore, not suitable for
regular MALDI-MS sequence analysis or peptide map compar-
ison. These spots had molecular weights between 27 and 25 kDa,
and it seemed possible that they could be associated to LPS (see
Fig. 1. Envelope fractions of B. abortus 2308 wild type and BvrRBvrS
mutants contain different amounts of group 3 Omps. SDS-proteinase K ex-
tracts or outer membrane fragments were analyzed on SDS12% PAGE gels
and either silver stained for proteins or electroblotted and developed with
anti-Omp25 mAbs. The arrow marks the position of the group 3 Omps band.
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above). To investigate this, a two-step Western blot of outer
membrane fragments was performed by probing the membrane
first with the anti-Omp25 (Omp3a) and then with the anti-LPS
mAbs. The results were registered after each step, and the
reactions were superposed using standard software. This analysis
demonstrated that spots 7 and 8 colocalized with the lower
section of the LPS complexes that migrated in the acidic region
of the 2DGE (data not shown).
It has been observed that the expression and apparent mo-
lecular weight of Omp3a in SDSPAGE changes with time under
regular culture conditions (27). To examine whether the heter-
ogeneity of the group 3 Omps found by 2DGE analysis related
to this observation, we analyzed the outer membrane fractions
of the bvrR and bvrS mutants obtained at early and late bacterial
growth. The results (not shown) demonstrated that the protein
pattern was the same at the two stages of growth.
To look for further differences in protein expression, total
bacterial SDS extracts and cytosols from the wild-type strain and
the bvrR and bvrS mutants were subjected to 2DGE analysis.
However, no significant qualitative or quantitative differences
were observed in these materials.
Omp3b Is a Hitherto Unnoticed B. abortus Omp That Is Absent in bvrR
and bvrS Mutants. MALDI-MS and peptide mass mapping re-
vealed that the five Omp3b spots in the wild-type strain had the
same amino acid sequence (data not shown), and possible
explanations for its apparent heterogeneity are the same as those
proposed for Omp3a. Partial amino acid sequences were com-
pared against preliminary B. suis genome sequence data, and
PCR primers were designed to clone and sequence B. abortus
omp3b. The whole sequence (GenBank accession no. AJ313014)
contained an ORF with a potential ribosome-binding site lo-
cated 5 bp upstream of the initiation codon. The omp3b ORF
encoded a protein of 212 amino acid residues with a calculated
mass of 22 kDa and a pI of 9.1. The analysis of the deduced amino
acid sequence predicted an outer membrane localization of the
protein and revealed homology (E value  1.077e-39) with the
OmpA group of bacterial Omps (28). A database search showed
that Omp3b had 29% identity (47% similarity) to RopB from the
plant endosymbiont Rhizobium leguminosarum, 29% identity
(45% similarity) to Omp31 from Brucella melitensis, and 26%
identity (45% similarity) to Omp3a (Omp25) from different
Brucella species. The sequence presents a putative signal peptide
of approximately 23 amino acids and a phenylalanine residue as
a C-terminal amino acid, required for efficient translocation of
Omps (29). Secondary structure prediction suggested a predom-
inant extended conformation, with eight putative -sheets, five
of them hydrophobic. However, the overall hydrophobicity was
only moderate (see Fig. 5, which is published as supporting
information on the PNAS web site, www.pnas.org).
Omp3a and Omp3b Expression Is Transcriptionally Regulated by
BvrRBvrS. Omp3a was not detected by Western blot analysis of
total soluble and purified cytoplasmic extracts of the bvrS mutant
(not shown), strongly suggesting that this Omp was not accu-
mulated in the bacterial cytoplasm and that its absence in the
envelope could not be due to lack of translocation. Thus, we
considered the hypothesis that expression of these proteins could
be transcriptionally regulated and, accordingly, the -galactosi-
dase activity of omp3a::lacZ and omp3b::lacZ transcriptional
fusions was investigated (Fig. 3). The results showed that the
activity of the omp3a and omp3b promoters was decreased in
both bvrR and bvrS mutants as compared with that in the wild
type or in the reconstituted bvrR 65.21p. These results demon-
strate that omp3a and omp3b are under the transcriptional
control of BvrRBvrS. Future DNA binding experiments will
clarify whether this is the result of direct control by BvrR or is
mediated through an intermediate regulatory system.
Omp3a and Omp3b Homologues Are Present in Members of the
Rhizobiaceae. Using the B. abortus Omp3a and Omp3b sequences,
we searched for homologous genes in the available genomes of
B. melitensis and phylogenetically related bacteria (A. tumefa-
ciens, S. meliloti, and M. loti). The search yielded a surprising
number of homologues: seven in B. melitensis and in M. loti, three
in A. tumefaciens, and two in S. meliloti. The corresponding
protein sequences were aligned with the CLUSTAL W program,
and a neighbor-joining tree derived from a distance-matrix was
obtained (Fig. 4). According to this analysis, these proteins can
be divided into four main groups: (i) sequences closely similar to
Omp3a, including RopB and AopB; (ii) sequences closely similar
to Omp3b; (iii) sequences only present in M. loti; and
(iv) sequences closely similar to Omp31 only present in Brucella.
Fig. 2. Dysfunction of bvrR and bvrS alters the profile of B. abortus group 3 Omps. 2DGE (A and B) and the corresponding Western blot analysis (C and D) of
outer membrane fragments of B. abortus 2308 wild type and BvrS mutant. The arrows indicate the silver-stained Omp3a and Omp3b spot groups. Numbers
indicate spots immunodetected with anti-Omp25 mAbs. Notice that spots marked as Omp3a in A are the same as spots 1, 2, and 3 in C, and that spot ‘‘a’’ is detected
in the wild type but only barely in the mutant. On the contrary, spots , , and  present in the mutant were not detected in the wild type. Trace amounts of
spot 9 were detected in the mutant.
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Discussion
Brucella lacks classical virulence factors such as toxins or ad-
hesins, and its virulence seems ascribed to type IV secretion
systems and to the peculiar properties of the cell envelope (1).
In this respect, the results presented here stress the role of the
cell envelope in Brucella pathogenicity because they demon-
strate that BvrRBvrS regulates the expression of B. abortus
Omps. Two major sets of proteins, Omp3a (formerly Omp25)
and Omp3b, related to B. melitensis Omp31 (absent in B.
abortus), to RopB of R. leguminosarum, and to AopB of A.
tumefaciens, were identified as regulated by BvrRBvrS.
The Omp3b protein described here has features reported for
other bacterial Omps such as the characteristic eight membrane
spanning amphipathic -sheets, no high overall hydrophobicity,
presence at the amino-terminal region of a signal peptide, and
phenylalanine as the carboxyl-terminal residue (29). Thus, it is
concluded that Omp3b is a hitherto nondescribed Brucella Omp.
The facts that Omp3a and Omp3b are severely diminished or
absent, and that the promoter activities of omp3a and omp3b are
also reduced in the bvrR and bvrS mutants, indicate that the
synthesis of these proteins is under the control of the BvrRBvrS
two-component system. Although experimental evidence is lack-
ing, it might be that this system also regulates the expression of
other Omps because we observed a decrease of protein spot ‘‘a’’
and an increase of protein spots , , and . It is also possible
that the increase in some protein spots and concomitant absence
or reduction of Omp3a and Omp3b in the bvrR and bvrS mutants
result from a compensatory effect to maintain the homeostasis
of the outer membrane. An alternative possibility is suggested by
the relatively high number of omp3 genes present in Brucella,
particularly intriguing when considering that only Omp3a and
Omp3b were identified. It is conceivable that some could code
for the protein spots (such as , , and ) that could not be
analyzed by MALDI-MS for technical reasons, even though it is
also possible that some of these genes are not expressed under
laboratory conditions. If so, these omp genes would not be an
exception because B. abortus carries two porin genes (omp2a and
omp2b), only one of which is expressed in vitro (30).
In a previous study (2), we found that BvrRBvrS mutants are
attenuated in the mouse model, and Edmonds et al. (6, 7) have
reported that omp3a-deficient mutants, which keep intact the
BvrRBvrS system, are attenuated in mice, cattle, and pregnant
goats. The comparison of the results obtained in mice shows that,
whereas the BvrRBvrS mutants are cleared from spleens by the
second week, the omp3a mutants last longer than 4 weeks (more
than 18 weeks for the parental strain). Thus, although both kinds
of mutants are attenuated, attenuation is more intense in the
former. This is consistent with the characteristic control of
multiple elements by two-component regulatory systems. In-
deed, it is necessary to study omp3b and double omp3a-omp3b
mutants to determine whether the attenuation of BvrRBvrS
mutants is due only to down-regulation of Omp3 proteins or
whether additional factors are also involved. The same mutants
should be examined for those outer membrane defects charac-
teristic of BvrRBvrS (i.e., polycation sensitivity, altered outer
membrane hydrophobicity and permeability, etc.).
B. suis Omp3a has been shown to be involved in the negative
regulation of TNF- production after infection of human mac-
rophages, supporting a role for this protein in Brucella capability
to survive within cells (31). Furthermore, we have found recently
that bvrS mutants do not stimulate the generation of active forms
of small GTPases of the Rho family on cell contact (32),
indicating that this two-component system is also necessary for
establishing an adequate cross talk with the host cell. In contrast
to wild-type bacteria, BvrRBvrS mutants are poor cell invaders
and, when ingested by professional and nonprofessional phago-
cytes, they are directed to lysosomes and destroyed (2). Taken
together, these observations and the results of the present study
lead to the hypothesis that BvrRBvrS regulates the expression
of Omps involved in cell invasion and also possibly in intracel-
lular survival, perhaps through a direct or indirect control of
intracellular trafficking. This could be due to a role of group 3
proteins in the interaction with cell surface receptors, but also
Fig. 3. Omp3a and Omp3b expression is transcriptionally regulated by
BvrRBvrS. The-galactosidase activity of omp3a::lacZ (A) and omp3b::lacZ (B)
transcriptional fusions was investigated in four genetic backgrounds: (1) B.
abortus wild-type 2308; (2) bvrS mutant 2.13; (3) bvrR mutant 65.21; and
(4) reconstituted bvrR 65.21p. The values are the mean and the standard error
of three independent assays.
Fig. 4. Neighbor-joining tree derived from distance-matrix analysis of 22–
31-kDa Omps sequences of M. loti (Ml), B. melitensis (Bm), S. meliloti (Sm), R.
leguminosarum (Rl), and A. tumefaciens (At). The names of the corresponding
genes (as they appear in GenBank) are in brackets.
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with internal receptors aimed to detect intracellular parasite
molecules (33). However, because BvrRBvrS mutants have
properties indicative of overall outer membrane alteration, it
cannot be excluded that deficient internalization relates to this
rather than to the Omp3 deficiency by itself. It also possible that
an outer membrane structural stability is necessary for the
correct assembly and functioning of the VirB membrane com-
ponents known to be involved in the control of intracellular
trafficking (34). Although these hypotheses and observations
concern the role of Omp3 in intracellular survival, they do not
exclude the contribution of other outer membrane components,
such as LPS, in virulence (1), or their regulation by BvrRBvrS.
This aspect is also currently under investigation.
The similarity of the Brucella BvrRBvrS system with some of
the chromosomally encoded two-component regulatory systems
present in plant endosymbionts and pathogens of the -2 Pro-
teobacteria is considerably higher than with other known two-
component systems involved in bacterial virulence (2). S. meliloti
ChvIExoS regulates production of polysaccharides like succi-
noglycans (8), but these kinds of molecules have not been
described in Brucella, and we have evidence that production of
Brucella native hapten polysaccharides and periplasmic cyclic
glucans is not affected by mutation of bvrR and bvrS (unpub-
lished results). However, the fact that the ChvIExoS and
ChvIChvG of S. meliloti and A. tumefaciens are also critical for
symbiosis and parasitism strongly argues in favor of the hypoth-
esis that these systems are crucial for the adaptation to eukary-
otic pericellular or intracellular habitats. From this perspective,
the high homology displayed by Omp3a, Omp3b, and their
Rhizobiaceae counterparts becomes very significant in the light
of the data presented here and in previous works. In R. legu-
minosarum, RopB (Fig. 4), which is expressed in explanted
bacterial cells (35), is severely decreased during bacteroid for-
mation (36). This is also true of R. leguminosarum group III
Omps such as RopA (37). Moreover, A. tumefaciens AopB, also
highly homologous to Omp3a (Fig. 4), is involved in tumorigen-
esis (38). Obvious comparisons between the lifestyle of Brucella
and rhizobiae emerge (39) and, on this basis, it can be predicted
that expression of RopB, RopA, AopB, and other proteins
homologous to Brucella group 3 Omps are both under the
control of systems homologous to BvrRBvrS and critical to
establish prokaryotic–eukaryotic cell interactions. At least with
regard to AopB, this prediction is confirmed by the results
presented in the accompanying paper by Li et al (43).
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